8
Participants
Start Date
April 30, 2015
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
LB1148
Placebo
New York Methodist Hospital, Brooklyn
University of Virginia Health System, Charlottesville
Wake Forest Baptist Health, Winston-Salem
UNC Chapel Hill, Chapel Hill
Providence Hospital, Mobile
Vanderbilt University Medical Center, Nashville
University of Louisville Hospital Laboratory, Louisville
ARH Regional Medical Center, Hazard
Mercy St. Vincent Medical Center, Clinical Research Offices, Toledo
University of Michigan Health Center, Ann Arbor
Henry Ford Hospital, Detroit
University of Iowa, Iowa City
Froedtert Hospital and Medial College of Wisconsin, Milwaukee
Mayo Clinic Labs - Rochester Campus, Rochester
St. Patrick Hospital, Missoula
OSF Saint Francis Medical Center, Peoria
Barnes Jewish Hospital, St Louis
University of Kansas Medical Center, Kansas City
OU Medical Center, Oklahoma City
Ben Taub Hospital, Houston
Long Beach Memorial Medical Center, Long Beach
Community Regional Medical Center, Fresno, Fresno
UC Davis Medical Center, Sacramento
Lahey Hospital and Medical Center, Burlington
Baystate Medical Center, Springfield
Cooper University Hospital, Camden
Peter Lougheed Centre, Calgary
Foothills Medical Centre, Calgary
St. Paul's Hospital, Vancouver
Royal Jubilee Hospital, Victoria
Victoria General Hospital, Victoria
St Boniface Hospital, Winnipeg
WHRA Winnipeg Health Sciences, Winnipeg
Nova Scotia Health Authority, Halifax
Lead Sponsor
Leading BioSciences, Inc
INDUSTRY